The Director of Geneva’s Campus Biotech is creating a new biotechnology and medical technology centre, bringing together different disciplines to find treatments that will save lives and improve the quality of life for patients. Since the beginning of modern pharmacology, the treatment of patients has relied on advances in medicine and biology to devise therapies […]
Health matters to all of us: we want to live longer and better lives as our standards of living rise. In this issue of Pictet Report, we take a look at some exciting developments in the diagnosis and treatment of illnesses, and at new models for providing affordable and accessible healthcare. The most significant factor […]
Growth is gradually normalising as cyclical weaknesses abate, and we expect fairly healthy rates of economic growth in developed economies in 2016. Moreover, we believe that an innovation shock could boost growth in the coming years — and indeed that a technological innovation shock has already begun, although its effects are still concentrated on certain sectors for now.
Since 2009, major central banks such as the US Federal Reserve, the European Central Bank (ECB), the Bank of Japan (BoJ) and others have largely determined the trends in the major asset classes of both emerging and developed countries: equities, sovereign and corporate bonds, and currencies. Investors found their guiding light in the central banks. […]
The Vix, a widely used measure of equity-market volatility, was in a systemic risk regime for 15 days this year, compared with just two days in 2014 and none at all in 2013, as shown by the chart below. This year’s experience of volatility is still not extensive in a historical comparison, but it still […]